MedTrace Logo

Extracorporeal Shock Wave Therapy on Spastic Equinus Foot in Stroke Patients

NCT06547684 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-09-19

No results posted yet for this study

Summary

The goal of this study is to evaluate long term effects of focused extracorporeal shock wave therapy (fESWT) on triceps surae spasticity in stroke patients according to the number of sessions applied.

Hypothesis: 3 sessions of fESWT on equinus foot in stroke patients improve spasticity and functionality for longer term than 1 session of fESWT.

Conditions

  • Stroke
  • Equinus Deformity
  • Spasticity, Muscle

Interventions

DEVICE

fESWT

Shock wave therapy will be applied with Duolith SD1 device (Storz Medical, Tagerwilen, Switzerland). Therapy will be administered in the gastrocnemius medial and lateral and in the soleus muscles. Parameters: 0.15mJ/mm2, 4-5 Hz, 1500 shoots/muscle.

Sponsors & Collaborators

  • Teresa Mateu Campos

    lead OTHER

Principal Investigators

  • Teresa Mª Mateu Campos · Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-28
Primary Completion
2024-09-07
Completion
2025-10-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06547684 on ClinicalTrials.gov